European Journal of Cancer
Volume 45, Issue 17 , Pages 3047-3053 , November 2009

Cancer diagnosis in first-degree relatives and non-small cell lung cancer risk: Results from a multi-centre case–control study in Europe

  • Adrian Cassidy

      Affiliations

    • Roy Castle Lung Cancer Research Programme, Cancer Research Centre, University of Liverpool, Liverpool, United Kingdom
    • Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States
    • These authors contributed equally to this work.
    • ,
  • Jessica Balsan

      Affiliations

    • INSERM U823, Institut Albert Bonniot, Team 11: “Outcome of cancer and critical illnesses”, Grenoble, France
    • These authors contributed equally to this work.
    • ,
  • Aurélien Vesin

      Affiliations

    • INSERM U823, Institut Albert Bonniot, Team 11: “Outcome of cancer and critical illnesses”, Grenoble, France
    • ,
  • Xifeng Wu

      Affiliations

    • Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States
    • ,
  • Triantafillos Liloglou

      Affiliations

    • Roy Castle Lung Cancer Research Programme, Cancer Research Centre, University of Liverpool, Liverpool, United Kingdom
    • ,
  • Christian Brambilla

      Affiliations

    • Institut Albert Bonniot, Université Joseph Fourier, INSERM U823; Grenoble, France
    • ,
  • Jean-François Timsit

      Affiliations

    • INSERM U823, Institut Albert Bonniot, Team 11: “Outcome of cancer and critical illnesses”, Grenoble, France
    • Corresponding Author InformationCorresponding authors: Fax: +44 151 794 8999 (J.K. Field), +33 04 76 76 55 69 (J.-F. Timsit).
    • ,
  • John K. Field

      Affiliations

    • Roy Castle Lung Cancer Research Programme, Cancer Research Centre, University of Liverpool, Liverpool, United Kingdom
    • Corresponding Author InformationCorresponding authors: Fax: +44 151 794 8999 (J.K. Field), +33 04 76 76 55 69 (J.-F. Timsit).
    • ,
  • EUELC Consortium

      Affiliations

    • European Early Lung Cancer (EUELC) Consortium: Christian Brambilla, Institut Albert Bonniot; Université Joseph Fourier; INSERM U823;Grenoble, France; Yves Martinet, Centre Hospitalier Universitaire de Nancy, France; Frederik B. Thunnissen, Department of Pathology, Canisius Wilhelmina Ziekenhuis, Nijmegen, The Netherlands and Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands; Peter J. Snijders, Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands; Gabriella Sozzi, Department of Experimental Oncology and Laboratories, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Angela Risch, German Cancer Research Centre, Heidelberg, Germany; Heinrich D. Becker, Thoraxklinik at Heidelberg University, Heidelberg, Germany; J. Stuart Elborn, Respiratory Medicine Research Group, Centre for Infection and Immunity, Queen’s University, Belfast, United Kingdom; Nicholas D. Magee, Respiratory Medicine Research Group, Centre for Infection and Immunity, Queen’s University, Belfast, United Kingdom; Luis M. Montuenga, Center for Applied Medical Research (CIMA), University of Navarra, Spain; Ken J. O’Byrne, St. James Hospital, Dublin, Ireland; David J. Harrison, University of Edinburgh, Edinburgh, United Kingdom; Jacek Niklinski, Medical Academy of Bialystok, Bialystok, Poland; John K. Field Roy Castle Lung Cancer Research Programme, Cancer Research Centre, University of Liverpool, Liverpool, United Kingdom.

Received 6 February 2009 ,Revised 1 May 2009 ,Accepted 6 May 2009.

References 

  1. Ferlay J, Autier P, Boniol M, et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007;18:581–592
  2. Amundadottir LT, Thorvaldsson S, Gudbjartsson DF, et al. Cancer as a complex phenotype: pattern of cancer distribution within, beyond the nuclear family. PLoS Med. 2004;1:e65
  3. Mayne ST, Buenconsejo J, Janerich DT. Familial cancer history and lung cancer risk in United States nonsmoking men and women. Cancer Epidemiol Biomarkers Prev. 1999;8:1065–1069
  4. Hershberger PA, Vasquez AC, Kanterewicz B, et al. Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands. Cancer Res. 2005;65:1598–1605
  5. Stabile LP, Davis AL, Gubish CT, et al. Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res. 2002;62:2141–2150
  6. Tokuhata GK, Lilienfeld AM. Familial aggregation of lung cancer in humans. J Natl Cancer Inst. 1963;30:289–312
  7. Jonsson S, Thorsteinsdottir U, Gudbjartsson DF, et al. Familial risk of lung carcinoma in the Icelandic population. JAMA. 2004;292:2977–2983[Erratum in: JAMA 2005;293:163]
  8. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer – analyses of cohorts of twins from Sweden, Denmark, and Finland. New Engl J Med. 2000;343:78–85
  9. Amos CI, Wu X, Broderick P, et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet. 2008;40:616–622
  10. Hung RJ, McKay JD, Gaborieau V, et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature. 2008;452:633–637
  11. Thorgeirsson TE, Geller F, Sulem P, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature. 2008;452:638–642
  12. Wang Y, Broderick P, Webb E, et al. Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet. 2008;40:1407–1409
  13. McKay JD, Hung RJ, Gaborieau V, et al. Lung cancer susceptibility locus at 5p15.33. Nat Genet. 2008;40:1404–1406
  14. Li X, Hemminki K. Familial and second lung cancers: a nation-wide epidemiologic study from Sweden. Lung Cancer. 2003;39:255–263
  15. Bromen K, Pohlabeln H, Jahn I, Ahrens W, Jockel KH. Aggregation of lung cancer in families: results from a population-based case–control study in Germany. Am J Epidemiol. 2000;52:497–505
  16. Kreuzer M, Kreienbrock L, Gerken M, et al. Risk factors for lung cancer in young adults. Am J Epidemiol. 1998;147:1028–1037
  17. Zhang Y, Shu XO, Gao YT, et al. Family history of cancer and risk of lung cancer among nonsmoking Chinese women. Cancer Epidemiol Biomarkers Prev. 2007;16:2432–2435
  18. Lorenzo Bermejo J, Hemminki K. Familial lung cancer and aggregation of smoking habits: a simulation of the effect of shared environmental factors on the familial risk of cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:1738–1740
  19. Hemminki K, Sundquist J, Ji J. Familial risk for gastric carcinoma: an updated study from Sweden. Br J Cancer. 2007;96:1272–1277
  20. Gocyk W, Nikliński T, Olechnowicz H, et al. Helicobacter pylori, gastrin and cyclooxygenase-2 in lung cancer. Med Sci Monit. 2000;6:1085–1092
  21. Ece F, Hatabay N, Erdal N, et al. Does Helicobacter pylori infection play a role in lung cancer?. Respir Med. 2005;99:1258–1262
  22. Najafizadeh K, Falah Tafti S, Shiehmorteza M, Saloor M, Jamali M. H. pylori seroprevalence in patients with lung cancer. World J Gastroenterol. 2007;13:2349–2351
  23. Pharoah P. Genetic epidemiology of cancer: relatively risky relatives. Eur J Hum Genet. 2005;13:519–520
  24. Nitadori J, Inoue M, Iwasaki M, et al. Association between lung cancer incidence and family history of lung cancer: data from a large-scale population-based cohort study, the JPHC study. Chest. 2006;130:968–975
  25. Bondy ML, Strom SS, Colopy MW, Brown BW, Strong LC. Accuracy of family history of cancer obtained through interviews with relatives of patients with childhood sarcoma. J Clin Epidemiol. 1994;47:89–96
  26. Chang ET, Smedby KE, Hjalgrim H, Glimelius B, Adami HO. Reliability of self-reported family history of cancer in a large case–control study of lymphoma. J Natl Cancer Inst. 2006;98:61–68
  27. Bravi F, Bosetti C, Negri E, Lagiou P, La Vecchia C. Family history of cancer provided by hospital controls was satisfactorily reliable. J Clin Epidemiol. 2007;60:171–175
  28. Khoury MJ, Beaty TH, Liang KY. Can familial aggregation of disease be explained by familial aggregation of environmental risk factors?. Am J Epidemiol. 1988;127:674–683

PII: S0959-8049(09)00344-X

doi: 10.1016/j.ejca.2009.05.006

European Journal of Cancer
Volume 45, Issue 17 , Pages 3047-3053 , November 2009

Article Tools